Cited 0 times in Scipus Cited Count

GS-003: Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial

DC Field Value Language
dc.contributor.authorPark, JW-
dc.contributor.authorKim, YJ-
dc.contributor.authorKim, DY-
dc.contributor.authorBae, SH-
dc.contributor.authorPaik, SW-
dc.contributor.authorLee, YJ-
dc.contributor.authorLee, D-
dc.contributor.authorLee, HC-
dc.contributor.authorHan, SY-
dc.contributor.authorCheong, JY-
dc.contributor.authorKwon, OS-
dc.contributor.authorYeon, JE-
dc.contributor.authorKim, BH-
dc.contributor.authorHwang, JS-
dc.date.accessioned2019-12-10T06:53:41Z-
dc.date.available2019-12-10T06:53:41Z-
dc.date.issued2018-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/17792-
dc.language.isoen-
dc.titleGS-003: Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial-
dc.typeArticle-
dc.contributor.affiliatedAuthor정, 재연-
dc.type.localJournal Papers-
dc.identifier.doi10.1016/S0168-8278(18)30222-8-
dc.citation.titleJournal of hepatology-
dc.citation.volume68-
dc.citation.numberS1-
dc.citation.date2018-
dc.citation.startPageS2-
dc.citation.endPageS2-
dc.identifier.bibliographicCitationJournal of hepatology, 68(S1). : S2-S2, 2018-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1600-0641-
dc.relation.journalidJ001688278-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Gastroenterology
Files in This Item:
10.1016_s0168-8278(18)30222-8.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse